Essa Pharma Inc

-0.02 (-0.83%)
Earnings Announcements

Essa Pharma Reports Quarterly Net Loss Of $0.20/Shr

Published: 08/04/2022 11:48 GMT
Essa Pharma Inc (EPIX) - Essa Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2022.
Qtrly Net Loss of $0.20 Loss per Common's Cash Position is Expected to Be Sufficient to Fund Current and Planned Operations Through 2024.
Q3 Earnings per Share View $-0.27 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33

More details on our Analysts Page.